Avadel Pharmaceuticals plc each representing one Ordinary Share (AVDL): Price and Financial Metrics
GET POWR RATINGS... FREE!
AVDL Stock Price Chart Interactive Chart >
AVDL Price/Volume Stats
| Current price | $8.18 | 52-week high | $10.20 |
| Prev. close | $8.91 | 52-week low | $1.05 |
| Day low | $8.00 | Volume | 578,600 |
| Day high | $9.00 | Avg. volume | 455,132 |
| 50-day MA | $8.16 | Dividend yield | N/A |
| 200-day MA | $6.36 | Market Cap | 505.35M |
Avadel Pharmaceuticals plc each representing one Ordinary Share (AVDL) Company Bio
Avadel Pharmaceuticals plc develops and commercializes pharmaceutical products based on its proprietary drug delivery technology for primary care and sterile injectable markets in the United States, France, and Ireland. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. The company was founded in 1990 and is based in Dublin, Ireland.
Latest AVDL News From Around the Web
Below are the latest news stories about AVADEL PHARMACEUTICALS PLC that investors may wish to consider to help them evaluate AVDL as an investment opportunity.
Avadel Pharmaceuticals Requests Final FDA Approval for LUMRYZ™ (sodium oxybate) extended-release oral suspension- Submitted amendment on March 1, 2023 to the LUMRYZ NDA seeking final FDA approval DUBLIN, Ireland, March 02, 2023 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it has submitted an amendment to the U.S. Food and Drug Administration (“FDA”) requesting final approval for LUMRYZ for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. This s |
Avadel Pharmaceuticals Shows Big Promise -- And RiskHere's how I'd play the stock of this small-cap whose narcolepsy drug recently received good news. |
UPDATE 2-Jazz Pharma ruling clears U.S. roadblock for rival narcolepsy drugA U.S. appeals court ordered Jazz Pharmaceuticals Inc on Friday to de-list a patent related to its blockbuster narcolepsy drug Xyrem from the U.S. Food and Drug Administration's register of approved medications, in a win for rival drugmaker Avadel CNS Pharmaceuticals Inc. The decision by the U.S. Court of Appeals for the Federal Circuit removes an obstacle for Avadel to sell its own narcolepsy drug Lumryz. Avadel stock was up 4.2% Friday afternoon following the ruling, and Jazz stock was down 1.4%. |
Jazz Pharma ruling clears U.S. roadblock for rival narcolepsy drugA U.S. appeals court ordered Jazz Pharmaceuticals Inc on Friday to de-list a patent related to its blockbuster narcolepsy drug Xyrem from the U.S. Food and Drug Administration's register of approved medications, in a win for rival drugmaker Avadel CNS Pharmaceuticals Inc. The decision by the U.S. Court of Appeals for the Federal Circuit removes an obstacle for Avadel to sell its own narcolepsy drug Lumryz. Avadel stock was up 4.2% Friday afternoon following the ruling, and Jazz stock was down 1.4%. |
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)DUBLIN, Ireland, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel’s Board of Directors approved the grant of non-statutory options to two (2) new employees to purchase an aggregate of 28,000 ordinary shares under Avadel’s 2021 Inducement Plan. The awards were granted as an inducement material to the employees’ acceptance of employment with Avadel i |
AVDL Price Returns
| 1-mo | -2.39% |
| 3-mo | 20.29% |
| 6-mo | 63.27% |
| 1-year | 16.52% |
| 3-year | 34.32% |
| 5-year | 14.41% |
| YTD | 14.25% |
| 2022 | -11.39% |
| 2021 | 20.96% |
| 2020 | -11.52% |
| 2019 | 192.64% |
| 2018 | -68.54% |
Continue Researching AVDL
Want to see what other sources are saying about Avadel Pharmaceuticals Plc's financials and stock price? Try the links below:Avadel Pharmaceuticals Plc (AVDL) Stock Price | Nasdaq
Avadel Pharmaceuticals Plc (AVDL) Stock Quote, History and News - Yahoo Finance
Avadel Pharmaceuticals Plc (AVDL) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...